{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:48Z","timestamp":1791355848392,"version":"4.3.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recent evidence suggests that chronic lymphocytic leukemia (CLL) might occur following a response to an infectious agent. We conducted a population-based study including 4249 CLL patients diagnosed in Denmark from 1977 to 1997 and 15\u2009690 frequency-matched controls to quantify risk of CLL following various airway infections. Through data linkage we gathered information on hospital inpatient\/outpatient discharges that listed infections present at least 1 year prior to CLL. Using logistic regression, we calculated odds ratios (ORs) and 95% confidence intervals (CIs). Personal history of pneumonia was associated with significantly increased CLL risk (OR = 1.4; 1.2-1.8); risk was restricted to 1 to 4.99 years prior to CLL diagnosis (OR = 1.6; 1.2-2.0). Individuals with 3 or more prior pneumonia events had a significant 2.5-fold (1.1-5.6) elevated CLL risk, and risk increased with the number of pneumonia episodes (Ptrend &lt; .001). None of 9 other respiratory-tract infections was significantly associated with CLL risk. Pneumonia might be a potential CLL trigger or it could represent premalignant immune disruption preceding CLL.<\/jats:p>","DOI":"10.1182\/blood-2006-08-044008","type":"journal-article","created":{"date-parts":[[2006,11,3]],"date-time":"2006-11-03T03:18:19Z","timestamp":1162523899000},"page":"2198-2201","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":88,"title":["Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia"],"prefix":"10.1182","volume":"109","author":[{"given":"Ola","family":"Landgren","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Rapkin","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Caporaso","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Mellemkjaer","sequence":"additional","affiliation":[{"name":"Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gridley","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,11,2]]},"reference":[{"key":"2019111715492773000_B1","unstructured":"Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review 1975-2003. 2006;Bethesda MD National Cancer Institute."},{"key":"2019111715492773000_B2","doi-asserted-by":"crossref","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med2005; 352:804\u2013815.","DOI":"10.1056\/NEJMra041720"},{"key":"2019111715492773000_B3","doi-asserted-by":"crossref","unstructured":"Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood2004; 104:1850\u20131854.","DOI":"10.1182\/blood-2004-01-0341"},{"key":"2019111715492773000_B4","doi-asserted-by":"crossref","unstructured":"Thorselius M, Krober A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3\u201321-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood2006; 107:2889\u20132894.","DOI":"10.1182\/blood-2005-06-2227"},{"key":"2019111715492773000_B5","doi-asserted-by":"crossref","unstructured":"Kienle D, Benner A, Krober A, et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood2006; 107:2090\u20132093.","DOI":"10.1182\/blood-2005-04-1483"},{"key":"2019111715492773000_B6","doi-asserted-by":"crossref","unstructured":"Messmer BT, Albesiano E, Messmer D, Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood2004; 103:3490\u20133495.","DOI":"10.1182\/blood-2003-10-3407"},{"key":"2019111715492773000_B7","doi-asserted-by":"crossref","unstructured":"Capello D, Guarini A, Berra E, et al. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia2004; 18:1941\u20131947.","DOI":"10.1038\/sj.leu.2403537"},{"key":"2019111715492773000_B8","doi-asserted-by":"crossref","unstructured":"Landgren O, Engels EA, Caporaso NE, et al. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood2006; 108:292\u2013296.","DOI":"10.1182\/blood-2005-11-4620"},{"key":"2019111715492773000_B9","doi-asserted-by":"crossref","unstructured":"Hamblin T. Is chronic lymphocytic leukemia a response to infectious agents? Leuk Res2006; 30:1063\u20131064.","DOI":"10.1016\/j.leukres.2005.11.022"},{"key":"2019111715492773000_B10","doi-asserted-by":"crossref","unstructured":"Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest2004; 113:1008\u20131016.","DOI":"10.1172\/JCI19399"},{"key":"2019111715492773000_B11","doi-asserted-by":"crossref","unstructured":"Chiorazzi N and Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol2003; 21:841\u2013894.","DOI":"10.1146\/annurev.immunol.21.120601.141018"},{"key":"2019111715492773000_B12","doi-asserted-by":"crossref","unstructured":"Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet1988; 1:292\u2013293.","DOI":"10.1016\/S0140-6736(88)90367-4"},{"key":"2019111715492773000_B13","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification\u2014from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol2000; 11:suppl 1, 3\u201310.","DOI":"10.1093\/annonc\/11.suppl_1.S3"},{"key":"2019111715492773000_B14","doi-asserted-by":"crossref","unstructured":"Goldin LR, Landgren O, McMaster ML, et al. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev2005; 14:2402\u20132406.","DOI":"10.1158\/1055-9965.EPI-05-0346"},{"key":"2019111715492773000_B15","doi-asserted-by":"crossref","unstructured":"Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst2006; 98:1321\u20131330.","DOI":"10.1093\/jnci\/djj361"},{"key":"2019111715492773000_B16","doi-asserted-by":"crossref","unstructured":"Thomsen RW, Riis A, Norgaard M, et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med2006; 259:410\u2013417.","DOI":"10.1111\/j.1365-2796.2006.01629.x"},{"key":"2019111715492773000_B17","doi-asserted-by":"crossref","unstructured":"Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood2006; 107:904\u2013906.","DOI":"10.1182\/blood-2005-08-3449"},{"key":"2019111715492773000_B18","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med2002; 346:564\u2013569.","DOI":"10.1056\/NEJMoa01133202"},{"key":"2019111715492773000_B19","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med2006; 354:1362\u20131369.","DOI":"10.1056\/NEJMoa054494"},{"key":"2019111715492773000_B20","doi-asserted-by":"crossref","unstructured":"Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood2004; 104:607\u2013618.","DOI":"10.1182\/blood-2004-01-0037"},{"key":"2019111715492773000_B21","doi-asserted-by":"crossref","unstructured":"Bergsagel PL and Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol2005; 23:6333\u20136338.","DOI":"10.1200\/JCO.2005.05.021"},{"key":"2019111715492773000_B22","unstructured":"Kimby E, Mellstedt H, Nilsson B, Bjorkholm M, Holm G. Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS). Leukemia1989; 3:501\u2013504."},{"key":"2019111715492773000_B23","doi-asserted-by":"crossref","unstructured":"Kimby E, Mellstedt H, Bjorkholm M, Holm G. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol1989; 43:452\u2013459.","DOI":"10.1111\/j.1600-0609.1989.tb00335.x"},{"key":"2019111715492773000_B24","doi-asserted-by":"crossref","unstructured":"Marti GE, Rawstron AC, Ghia P, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol2005; 130:325\u2013332.","DOI":"10.1111\/j.1365-2141.2005.05550.x"},{"key":"2019111715492773000_B25","unstructured":"Landgren O, Rapkin J, Mellemkjaer L, Gridley G, Goldin LR, Engels EA. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica2006; 91:1697\u20131700."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/2198\/1478981\/zh800507002198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/2198\/1478981\/zh800507002198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T20:49:44Z","timestamp":1574023784000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/5\/2198\/23239\/Respiratory-tract-infections-and-subsequent-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,2]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,2]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-08-044008","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,2]]}}}